Sofosbuvir + ribavirin produces sustained response in 76% of genotype 1 HIV/HCV co-infected people
Simeprevir + sofosbuvir produces high sustained response rates for hard-to-treat patients in COSMOS trial
BMS interferon-free combination cures over 90% of genotype 1 hepatitis C in 12 weeks
Merck interferon-free combination shows high hepatitis C cure rate in early study
Need for expansion of hepatitis C screening among veterans, 'baby-boom' generation and pregnant women highlighted
AbbVie’s two-drug, interferon-free combination cures genotype 1b hepatitis C infection in 95%
High response rates with telaprevir triple therapy for HIV-positive men with acute hepatitis C
In ELECTRON trial, 100% of hard-to-treat patients cured with sofosbuvir/ledipasvir plus ribavirin or GS-9669
